scispace - formally typeset
Journal ArticleDOI

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Reads0
Chats0
TLDR
Mutations in the newly identified gene appear to be responsible for the pathogenesis of Autosomal recessive juvenile parkinsonism, and the protein product is named ‘Parkin’.
Abstract
Parkinson's disease is a common neurodegenerative disease with complex clinical features1. Autosomal recessive juvenile parkinsonism (AR-JP)2,3 maps to the long arm of chromosome 6 (6q25.2-q27) and is linked strongly to the markers D6S305 and D6S253 (ref. 4); the former is deleted in one Japanese AR-JP patient5. By positional cloning within this microdeletion, we have now isolated a complementary DNA clone of 2,960 base pairs with a 1,395-base-pair open reading frame, encoding a protein of 465 amino acids with moderate similarity to ubiquitin at the amino terminus and a RING-finger motif at the carboxy terminus. The gene spans more than 500 kilobases and has 12 exons, five of which (exons 3–7) are deleted in the patient. Four other AR-JP patients from three unrelated families have a deletion affecting exon 4 alone. A 4.5-kilobase transcript that is expressed in many human tissues but is abundant in the brain, including the substantia nigra, is shorter in brain tissue from one of the groups of exon-4-deleted patients. Mutations in the newly identified gene appear to be responsible for the pathogenesis of AR-JP, and we have therefore named the protein product ‘Parkin’.

read more

Citations
More filters
Journal ArticleDOI

CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins

TL;DR: It is established that CHIP does not play an exclusive role in regulating the turnover of Hsp90 client signaling proteins or expanded glutamine tract proteins, and it is shown that the Hsp70-dependent E3 ligase Parkin acts redundantly to CHIP on some substrates.
Journal ArticleDOI

Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease

TL;DR: It is shown that asparagine endopeptidase cleaves human α-synuclein, triggers its aggregation and escalates its neurotoxicity, thus leading to dopaminergic neuronal loss and motor impairments in a mouse model, and AEP's role as a key mediator of α- synuclein-related etiopathological effects in PD is supported.
Journal ArticleDOI

The Function of Autophagy in Neurodegenerative Diseases

TL;DR: This review focuses on the recent findings regarding the autophagic process and the involvement of autophagy in neurodegenerative diseases and its role in Alzheimer's disease and Parkinson's disease.
Journal ArticleDOI

Drosophila Models of Neurodegenerative Disease

TL;DR: A general overview of fly models pertinent to trinucleotide repeat expansion disorders, Alzheimer’s, and Parkinson's diseases are provided, and key genetic modifiers that have been identified to date using such models are highlighted.
Journal ArticleDOI

Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD.

TL;DR: All aspects of quality of life, including motor, systemic, emotional, and social dimensions, significantly improved with long-term STN stimulation in patients with PD.
References
More filters
Book

Molecular Cloning: A Laboratory Manual

TL;DR: Molecular Cloning has served as the foundation of technical expertise in labs worldwide for 30 years as mentioned in this paper and has been so popular, or so influential, that no other manual has been more widely used and influential.
Journal ArticleDOI

Mutation in the α-synuclein gene identified in families with Parkinson's disease

TL;DR: A mutation was identified in the α-synuclein gene, which codes for a presynaptic protein thought to be involved in neuronal plasticity, in the Italian kindred and in three unrelated families of Greek origin with autosomal dominant inheritance for the PD phenotype.
Journal ArticleDOI

Alpha-synuclein in Lewy bodies.

TL;DR: Strong staining of Lewy bodies from idiopathic Parkinson's disease with antibodies for α-synuclein, a presynaptic protein of unknown function which is mutated in some familial cases of the disease, indicates that the LewY bodies from these two diseases may have identical compositions.
Journal ArticleDOI

Mitochondrial complex I deficiency in Parkinson's disease.

TL;DR: Results indicated a specific defect of Complex I activity in the substantia nigra of patients with Parkinson's disease, which adds further support to the proposition that Parkinson’s disease may be due to an environmental toxin with action(s) similar to those of MPTP.
Journal ArticleDOI

The ubiquitin-proteasome proteolytic pathway

TL;DR: Two studies clearly demonstrate that the ubiquitin-proteasome system is involved not only in complete destruction of its protein substrates, but also in limited proteolysis and posttranslational processing in which biologically active peptides or fragments are generated.
Related Papers (5)